Sunday, May 24, 2020 10:40:17 PM
Please critique, with extreme prejudice, the analysis below:
David:Topline should come by 7/7/20. If it is strong , the nwbo market cap should be at least $5 billion($5.00 per share).
Frank:Why NWBO jumped 75 % on friday, 5/22/20:
1)Reardon et al at DFCI/Harvard/B and W announced in a 5/22/20 JAMA paper that BMS’s Opdivo was no better that Avastin(Novartis?/FDA approved) in GBM.JAMA Oncology
Source Reference: Reardon DA, et al "Effect of nivolumab vs bevacizumab in patients with recurrent glioblastoma: the CheckMate 143 phase 3 randomized clinical trial" JAMA Oncol 2020; DOI: 10.1001/jamaoncol.2020.1024.https://clinicaltrials.gov/ct2/show/NCT02017717?term=checkmate+143&draw=2&rank=1
2)a)Linda Liau(and her UCLA colleague scientist, Multuoglu) in a 5/22/20 JAMA accompanying editorial postulated that Opdivo would only be be better than Avastin in GBM if it was combined with Dc Vax L and ICLC, a TLR adjuvant.b)Reardon in a Medpage Today interview 5/22/20 said,” "Instead of PD-1 alone, we are probably going to need to give combination treatment to give the immune system a chance to fight the tumor."
Secondary Source
JAMA Oncology
Source Reference: Muftuoglu Y, Liau L "Results from the CheckMate 143 clinical trial: stalemate or new game strategy for glioblastoma immunotherapy?" JAMA Oncol 2020; DOI: 10.1001/jamaoncol.2020.0857.
(LL editorial published JAMA 5/22/20)
Miscellaneous field report on LL Keytruda combo work 5/24/20 : ("This trial(NCT04201873)just started in January. I know she had fantastic results with the poly iclc adjuvant(we have this paper/CR found). Combined with keytruda the results could be spectacular. She said it’s all in the timing. Gotta give the keytruda before surgery ."
Sent from my iPhone
On May 24, 2020, at 1:28 PM, Joseph H Pratt II <jhpratt2@icloud.com> wrote:
?
Harry:Do you know if Liau has seen results from the trial below(DC VAX L plus Keytruda)? Joe)
3)https://clinicaltrials.gov/ct2/show/NCT04201873?term=cloughesy&draw=2&rank=3. This is one supplementary nwbo trial I know about.There could be others in a clandestine state.In this trial Keytruda, ICLC, and DC Vax L are combo-ed.First patient dosed about 1/15/20, so Liau may know some results, but all is supposed to be secret , I think.
Chelsea Girls Questions:"Joe
Pls explain in one or two sentences
what is this in reference to
why is it important or critical, if it is
how does this trial impact nwbo
the Chelsea girls asked me about "supplementary trials" being run that would impact nwbo. I have no clue.
do you have an idea/?
thanks"
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM